TWC signs deal with Medlab

TerryWhite Chemmart has announced the signing of an agreement with Medlab to stock their clinical-standard range in TWC pharmacies across the country from April.

Medlab is a leading Australian medical life sciences company with strong heritage and experience in the development of professional vitamins and supplements.

The company’s products that will be available in TWC include ORS, a patented oral rehydration system and VSL3 Probiotic, a powder supplement for people suffering from IBS.

TerryWhite Chemmart Chief Executive Officer Anthony White said pharmacies across the network have developed credibility in the professional vitamin category and the addition of Medlab further strengthens this position.

“We are pleased to provide our customers with access to a comprehensive, clinically proven, professional range of vitamins that is scientifically backed by research and patents,” he said.

Mr White said he welcomed the Medlab range to the vitamins and supplement market in Australia as it provided more choice for customers seeking a clinical-grade product.

“The addition of Medlab nutraceuticals will provide an exciting and refreshing new alternative for customers and help to stimulate domestic market growth of the vitamin category,” he said.

TerryWhite Chemmart Professional Practice Pharmacist, Chris Campbell said “Medlab uses nanotechnology, via its Nanocelle™ delivery platform, to deliver medicines in nanoparticles that can be more readily absorbed when administered directly into the nose or mouth. This not only enhances the delivery of nutraceutical medicine, but its efficacy as well,” said Mr Campbell.

The introduction of Medlab across the TerryWhite Chemmart network will be supported through Masterclass training for pharmacists and pharmacy assistants, along with a strong promotional program.

Both Medlab and TerryWhite Chemmart are exhibiting at this year’s APP conference on the Gold Coast in March.

Must Read

New regional roadmaps for prioritising antimicrobial resistance

0
A new publication by the International Pharmaceutical Federation (FIP) identifies priority actions pharmacists should take to minimise antimicrobial resistance (AMR). The publication presents six...